Emerging Metabolic Therapies in Pulmonary Arterial Hypertension

Pulmonary hypertension (PH) is an enigmatic vascular disorder characterized by pulmonary vascular remodeling and increased pulmonary vascular resistance, ultimately resulting in pressure overload, dysfunction, and failure of the right ventricle. Current medications for PH do not reverse or prevent d...

Descripción completa

Detalles Bibliográficos
Autores principales: Harvey, Lloyd D., Chan, Stephen Y.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5406775/
https://www.ncbi.nlm.nih.gov/pubmed/28375184
http://dx.doi.org/10.3390/jcm6040043

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5406775/
https://www.ncbi.nlm.nih.gov/pubmed/28375184
http://dx.doi.org/10.3390/jcm6040043

Ejemplares similares